A comprehensive view of Genetic Disorders. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Lilly completes acquisition of Akouos, expanding its efforts to help people with genetic diseases; acquisition includes Akouos's portfolio of adeno-associated viral gene therapies to treat inner ear conditions, including sensorineural hearing loss
Published: December 01, 2022 by Eli Lilly & Co.
AstraZeneca’s Alexion completes US$68.0M acquisition of LogicBio Therapeutics; LogicBio has developed tech platforms to deliver and insert genes to address genetic diseases and a platform to improve viral vector manufacturing processes
Published: November 22, 2022 by Indian Pharma Industry: Policies
New short-read Transpore Rapid Karyotyping test uses samples collected from standard prenatal tests to detect extra, missing chromosomes in fetuses; same-day test could identify genetic problems that increase risk of miscarriage: Columbia University
Published: August 22, 2022 by The Griffon News (Missouri Western State College)
Premier Medical Laboratory Services adds noninvasive prenatal test that screens for chromosomal abnormalities such as Down Syndrome, indicates sex of baby, from blood sample; test is risk-free, highly accurate, covered by insurance for some pregnancies
Published: May 19, 2022 by PR Newswire
Pfizer starting Phase 3 study in US of injectable fordadistrogene movaparvovec mini-dystrophin gene therapy for ambulatory patients with Duchenne muscular dystrophy after FDA lifts clinical hold on drug; DMD has very limited treatment options
Published: May 09, 2022 by Contify Life Science News

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count